V. Nene et al., CHARACTERIZATION OF AN INSECT CELL-DERIVED THEILERIA-PARVA SPOROZOITEVACCINE ANTIGEN AND IMMUNOGENICITY IN CATTLE, Infection and immunity, 63(2), 1995, pp. 503-508
Previous data showed that six out of a group of nine cattle inoculated
with NS1-p67, a recombinant form of a 67-kDa Theileria parva sporozoi
te surface protein, were immune to East Coast fever. This bacterially
expressed antigen encoded all 709 amino acid residues of p67 fused to
the C-terminal end of 87 residues derived from NS1, a structural prote
in of influenza virus, and a linker DNA sequence. NS1-p67 lacked react
ivity with TpM 12, a monoclonal antibody to native p67, and had an est
imated molecular mass of 110 kDa, as opposed to the calculated mass of
85,000 Da. We have used the baculovirus expression system in an attem
pt to express this parasite protein in a native form and thereby incre
ase the protective capacity of the antigen. However, Spodoptera frugip
erda SF21AE cells infected with recombinant virus expressed p67 as a 1
00-kDa molecule. The host cells exhibited a limited capacity to glycos
ylate this molecule to a 110-kDa form, and p67 was not exported to the
surface membrane. TpM 12 did not bind to these recombinant forms but,
at time points late during viral infection, reacted with a molecule o
f about 70 kDa. Since the bulk of insect cell-derived p67 was not expr
essed in an appropriate form, we tested the immunogenicity of these pa
rtially processed recombinant p67 forms in cattle. Two groups of three
cattle were inoculated with antigen formulated either with saponin or
Freund's adjuvant. As seen previously with NS1-p67, all animals devel
oped high levels of anti-p67 antibodies that neutralized sporozoite in
fectivity in vitro, but antigen-specific T-cell proliferative response
s were not detected in peripheral blood. Given the caveat of the small
number of cattle analyzed, insect cell-derived p67 does not appear to
be superior to NS1-p67 as an immunogen, and the latter remains the mo
lecule of choice for the development of vaccines against East Coast fe
ver.